The Motley Fool fool.com 05 Aug, 2022 11:00 am

Schrödinger, Inc. (SDGR) Q2 2022 Earnings Call Transcript

SDGR earnings call for the period ending June 30, 2022.

Welcome to Schrodinger's conference call to review second quarter 2022 financial results.Welcome to today's call, during which we will provide an update on the company and review our second quarter 2022 financial results.Today, we reported second quarter software revenue of $30 million, a 25% increase over the prior year.We also recognized milestones from multiple collaborative programs during the second quarter, which helped drive drug discovery revenue of $8.

5 million for the second quarter and $87.During the second quarter, we submitted the IND for our MALT1 inhibitor, SGR-1505, and we are now clear to proceed with our phase 1 clinical trial.

Read full story at fool.com